Physician profile

Prejesh Philips

Surgical Oncology · Louisville, KY

NPI 1114183787

$8,824.08

in general payments reported to CMS, 2019-2025

34 companies · $1,388 in 2025

The $1,388 reported for 2025 was more than what 75% of Surgical Oncology providers received nationally (typical 2025 total: $288).

See the full distribution for Surgical Oncology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,307.69
Travel and Lodging$1,453.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $3,444.35 2019-2025 Axios, Overstitch Endoscopic Suturing System, Exalt Model D
Intuitive Surgical, INC. $2,129.97 2019
Asensus Surgical, INC. $1,079.45 2019
Abbvie INC. $355.74 2021-2025
Angiodynamics, INC. $251.95 2022-2024 Solero
Medtronic, INC. $244.30 2022-2023 Signia, Emprint
Dilon Technologies, INC. $166.14 2024 Hemoblast Bellows
Karl Storz Endoscopy-America $149.09 2023 Image1 S Connect
E.R. Squibb & Sons, L.L.C. $124.74 2022
Ethicon US, LLC $114.20 2020
Apollo Endosurgery US INC $95.40 2023 Overstitch Endoscopic Suturing System
Avita Medical Americas, LLC $91.98 2025 Permeaderm, Recell, Cohealyx
Amgen INC. $64.43 2019
W. L. Gore & Associates, INC. $58.20 2020
Astellas Pharma US INC $57.92 2023-2024 Xospata, Vyloy
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Kerecis Limited $36.17 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose
Celgene Corporation $35.29 2019
Bayer Healthcare Pharmaceuticals INC. $27.29 2019-2020
Eisai INC. $26.99 2020-2024
Tela Bio, INC. $25.46 2020-2021
Alcresta Therapeutics, INC. $24.68 2024 Relizorb
Micro-Tech Endoscopy USA, INC. $24.15 2024 Eyemax
Taiho Oncology, INC. $23.48 2025
Eagle Pharmaceuticals, INC. $19.86 2024
Novartis Pharmaceuticals Corporation $19.12 2020
Baudax Bio INC. $18.00 2022
Merck Sharp & Dohme LLC $16.65 2022
Janssen Biotech, INC. $15.59 2025 Erleada
Helsinn Therapeutics (U.S.), INC. $14.96 2021
Avanos Medical $14.71 2019
Axonics, INC. $14.37 2022
Advanced Accelerator Applications $14.17 2019
Acera Surgical, INC. $13.28 2023 Restrata Wound Matrix
Incyte Corporation $12.00 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Prejesh Philips

$8,824.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,388 reported for 2025 was more than what 75% of Surgical Oncology providers received nationally (typical 2025 total: $288).

https://glasscript.com/doctor/1294694/prejesh-philips

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.